Asia Tech Wire (Sep 13) -- China's Autobio Diagnostics Co Ltd (603658.SH) on Thursday entered into a strategic cooperation in the field of microbial mass spectrometer with Japan's Medical and Biological Laboratories Co., Ltd. (MBL).

The two companies will make full use of their respective strengths in the field of in vitro diagnostics to carry out all-round strategic cooperation in microbial mass spectrometry.

MBL focuses on clinical diagnostic and research reagent development, production and sales, covering the fields of immunology, molecular, epigenome, etc., and owns more than 80% of the autoimmune disease diagnostic market in Japan.